SECTOR:
Other therapeutics
FUND/VEHICLE:
Pivotal US; NFLS Direct Investment
INVESTMENT DATE:
2020
GEOGRAPHY:
North America
STATUS CURRENT/FORMER INVESTMENT:
Existing
WEBSITE:
Evommune is using the skin as the lens to uncover new approaches for accelerating the development of vital medicines across immunology and dermatology. Utilizing a novel screening platform, we identify molecules that are differentiated and that have a greater probability of being effective in treating patients